logo
Select company
Select metric
$ -242.36MConsolidated Income
VS
Market
6
Sector
8
Industry
10
History
-
$ 8.16Close
$ 6.38 - $ 26.7 52-Week Range
Ticker Information

Ticker

BCYC

Company Name

BICYCLE THERAPEUTICS PLC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

BICYCLE THERAPEUTICS PLC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

BCYC - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -242.36M
3/31/2025$ -203.22M
12/31/2024$ -169.03M
9/30/2024$ -166.28M
6/30/2024$ -165.37M
3/31/2024$ -168.16M
12/31/2023$ -180.66M
9/30/2023$ -161.54M
6/30/2023$ -139.99M
3/31/2023$ -124.22M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • BICYCLE THERAPEUTICS PLC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -37.98M.
  • Over the past 5 years, BICYCLE THERAPEUTICS PLC's average Cons. Inc. has been $ -121.96M.
  • The median Cons. Inc. for BICYCLE THERAPEUTICS PLC during this period was $ -118.47M
  • BICYCLE THERAPEUTICS PLC reached its highest Cons. Inc. over the past 5 years at $ -37.98M.
  • The lowest Cons. Inc. recorded by BICYCLE THERAPEUTICS PLC in the same timeframe $ -242.36M

BICYCLE THERAPEUTICS PLC's Cons. Inc. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cons. Inc. Benchmarks
CompanyCons. Inc.
ALMS : ALUMIS INC $ -227.52MVIR : VIR BIOTECHNOLOGY INC $ -550.23MABUS : ARBUTUS BIOPHARMA CORP $ -54.25MZBIO : ZENAS BIOPHARMA INC $ -177.01MCAPR : CAPRICOR THERAPEUTICS INC $ -69.98MAUTL : AUTOLUS THERAPEUTICS PLC $ -227.78MQURE : UNIQURE NV $ -199MRLAY : RELAY THERAPEUTICS INC $ -311.55MTNGX : TANGO THERAPEUTICS INC $ -145.57MFHTX : FOGHORN THERAPEUTICS INC $ -75.39M

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

BCYC - Consolidated Income, Last 5 years

$ -242.36M

Minimum

Jun 30, 2025

$ -37.98M

Maximum

Sep 30, 2020

$ -121.96M

Average

$ -118.47M

Median

Cons. Inc. Benchmark Analysis

The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.12M with a standard deviation of $ 116.68M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 378M
average$ 12.12M
median$ -2.09M
std$ 116.68M